Healthcare legislation business Frier Levitt has analyzed FDA enforcement steps against “analysis only” peptide suppliers. Their conclusion: the FDA considers a product’s classification according to its supposed use, not its disclaimers. When websites consist of dosage guides, reconstitution Guidelines, or hyperlink to community forums talkin